Isomorphic Labs

London, United Kingdom

Isomorphic Labs is an AI-first drug design and development company that transforms drug discovery to design and evaluate new medicines.

May 2026

Series B

Artificial Intelligence (AI)Biotechnology Life Science Medical

Top Investors

Temasek HoldingsThrive CapitalAlphabetCapitalGMGX

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Isomorphic Labs

Who are Isomorphic Labs's investors?

Isomorphic Labs's investors include Temasek Holdings, Thrive Capital, Alphabet, CapitalG, MGX.

Where is Isomorphic Labs headquartered?

Isomorphic Labs is headquartered in London, United Kingdom.

What does Isomorphic Labs do?

Isomorphic Labs is an AI-first drug design and development company that transforms drug discovery to design and evaluate new medicines.

What stage is Isomorphic Labs at?

Isomorphic Labs is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 12, 2026.

MLA

"Isomorphic Labs — Funding & Investors." VCBacked, May 12, 2026, https://www.vcbacked.co/company/isomorphic-labs. Accessed June 4, 2026.

APA

VCBacked. (2026). Isomorphic Labs — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/isomorphic-labs

Wikipedia (cite web)

{{cite web |title=Isomorphic Labs — Funding & Investors |url=https://www.vcbacked.co/company/isomorphic-labs |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 12, 2026.

Similar Companies in Artificial Intelligence (AI)